Ananda Pharma Plc (AQU:ANA)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.2750
0.00 (0.00%)
At close: Aug 13, 2025
-38.89%
Market Cap 11.82M
Revenue (ttm) 62.00
Net Income (ttm) -3.77M
Shares Out 4.30B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open n/a
Previous Close 0.2750
Day's Range n/a
52-Week Range 0.2750 - 0.5350
Beta 0.50
RSI 24.99
Earnings Date Oct 29, 2025

About Ananda Pharma

Ananda Pharma Plc, together with its subsidiaries, operates as a biopharmaceutical company that develops cannabidiol-based medicine to treat chronic conditions in the United Kingdom and internationally. Its lead product, MRX1, is in Phase 2a feasibility trials for endometriosis-related pain and in a Phase 2 efficacy study to investigate chemotherapy-induced peripheral neuropathy. The company also offers MRX2 and MRX2t, which are cannabinoid-based medicines in Phase 3 clinical trials for refractory epilepsies. In addition, it engages in crop pro... [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 12
Stock Exchange Aquis Exchange
Ticker Symbol ANA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.